Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

Glomeruloid microvascular proliferation (GMP) in breast cancer independently adversely affected survival (relative risk 1.9, 95% CI: 1.2–3.0), particularly among women who received adjuvant chemotherapy (10-year survival 27 vs 69%, P=0.0003), and was significantly associated with p53 overexpression...

Descripción completa

Detalles Bibliográficos
Autores principales: Goffin, J R, Straume, O, Chappuis, P O, Brunet, J-S, Bégin, L R, Hamel, N, Wong, N, Akslen, L A, Foulkes, W D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Molecular and Cellular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376955/
https://www.ncbi.nlm.nih.gov/pubmed/12966421
http://dx.doi.org/10.1038/sj.bjc.6601195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376955/
https://www.ncbi.nlm.nih.gov/pubmed/12966421
http://dx.doi.org/10.1038/sj.bjc.6601195

Ejemplares similares